Skip to main content

Table 1 Baseline characteristics in study male population

From: Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population

Characteristics

Total

(n = 2355)

MAFLD

(n = 515)

Non-MAFLD

(n = 1840)

P- Value

Age (years)

37.82 ± 11.10

39.84 ± 9.92

37.26 ± 11.35

< 0.001

Height (cm)

167.97 ± 5.54

167.98 ± 5.61

167.97 ± 5.53

0.967

Weight (kg)

65.87 ± 10.43

74.85 ± 9.58

63.36 ± 9.21

< 0.001

WC (cm)

80.87 ± 9.23

89.90 ± 6.75

78.34 ± 8.19

< 0.001

HC (cm)

91.51 ± 6.20

96.56 ± 5.59

90.10 ± 5.60

< 0.001

SBP (mmHg)

118.32 ± 15.48

123.53 ± 17.00

116.87 ± 14.70

< 0.001

DBP (mmHg)

77.00 ± 10.25

81.23 ± 11.34

75.82 ± 9.60

< 0.001

ALT (U/L)

39.00 (30.00–54.00)

54.00 (40.00–74.00)

36.00 (29.00–48.00)

< 0.001

Lipid profile

 TC (mmol/L)

5.71 ± 1.03

6.08 ± 1.03

5.60 ± 1.00

< 0.001

 TG (mmol/L)

1.13 (0.78–1.75)

1.88 (1.31–2.79)

1.00 (0.71–1.48)

< 0.001

 HDL (mmol/L)

1.40 ± 0.33

1.29 ± 0.40

1.44 ± 0.30

< 0.001

 LDL (mmol/L)

2.97 ± 0.80

3.28 ± 0.78

2.88 ± 0.79

< 0.001

Metabolic indices

 UA (μmol/L)

378.46 ± 79.68

420.29 ± 87.04

366.76 ± 73.37

< 0.001

 FPG (mmol/L)

5.20 (4.90–5.60)

5.40 (5.00–5.80)

5.10 (4.90–5.50)

< 0.001

 Insulin (mU/L)

6.38 (4.27–9.67)

10.46 (7.57–15.22)

5.61 (3.85–8.19)

< 0.001

 HOMA-IR

1.47 (0.97–2.31)

2.55 (1.80–3.75)

1.29 (0.87–1.90)

< 0.001

 HOMA-IS

0.68 (0.43–1.03)

0.39 (0.27–0.56)

0.78 (0.53–1.14)

< 0.001

 HOMA-β(%)

78.35 (49.82–118.33)

115.08 (79.45–164.45)

69.82 (45.86–104.74)

< 0.001

Hormones

 FSH (mIU/mL)

5.10 (3.58–7.53)

5.06 (3.63–7.53)

5.12 (3.56–7.54)

0.804

 LH (mIU/mL)

5.18 (3.97–6.72)

4.89 (3.67–6.42)

5.27 (4.05–6.81)

< 0.001

 Estradiol (pg/mL)

34.34 ± 10.13

32.58 ± 8.73

34.84 ± 10.44

< 0.001

 Testosterone (ng/mL)

6.26 ± 1.93

4.92 ± 1.48

6.64 ± 1.87

< 0.001

 SHBG (nmol/L)

38.35 (28.02–51.28)

25.84 (19.43–35.04)

41.97 (32.10–54.44)

< 0.001

  1. Abbreviations: MAFLD Metabolic-dysfunction associated fatty liver disease, WC Waist circumference, HC HIP circumference, SBP Systolic blood pressure, DBP Diastolic blood pressure, ALT Alanine transaminase, TC Total cholesterol, TG Triglyceride, HDL High-density lipoprotein, LDL Low-density lipoprotein, UA Uric acid, FPG Fasting plasma glucose, HOMA Homeostatic model assessment, FSH Follicle stimulating hormone, LH Luteinizing hormone, SHBG Sex hormone-binding globulin. Numeric variables are described by (mean ± SD) or median (interquartile range). P < 0.05 was accepted statistically significant